Consistently, we detected upregulated PP2A activity in the patient-derived NPC cultures, which was rescued by interfering both PPP2R2B and PPP2R2C with siRNA (Fig. 6D). This evidence concerns the gene PPP2R2B and nasopharyngeal carcinoma.